Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Our Therapy - Delcath
Delcath files new FDA application for chemo drug-device combination ...
Prospective Clinical and Pharmacological Evaluation of the Delcath ...
Delcath Systems Q4 Earnings Call Highlights
Delcath Systems Raises $16.3M Through Warrant Exercise to Advance ...
Delcath Systems announces US FDA acceptance of Hepzato Kit NDA resubmission
Delcath Announces Poster Presentation at the 2022 ASCO
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the ...
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial ...
Delcath Systems announce first commercial use of Hepzato Kit ...
Diagram of the percutaneous hepatic perfusion system. This Delcath ...
Delcath Systems Introduces Healthcare Setting Locator for Hepzato Kit ...
Delcath registers $100m offering - MassDevice
FDA approved Delcath Systems' Hepzato Kit (melphalan/Hepatic Delivery ...
B2i Digital on LinkedIn: We want to welcome Delcath Systems to the ROTH ...
Delcath Systems - Crunchbase Company Profile & Funding
Delcath Systems Announces U.S. Launch and First Commercial Treatment ...
Delcath Systems (DCTH) Announces Relisting On OTCQB - Cardiac Vascular News
Petition · Help Delcath Systems and cut the Boards Salaries! - United ...
5 DELCATH SYSTEMS, INC
Evaluation of Delcath Systems’ Generation 2 (GEN 2) Melphalan ...
Delcath Systems Corporate Presentation - (OTCQB: DCTH) January 2020 ...
DELCATH SYSTEMS, INC. - FORM 8-K - EX-99.1 - February 12, 2013
DCTH - Delcath Systems | Fundamentei
Delcath Systems, Inc is now enrolling patients at Moffitt Cancer Center ...
Delcath Systems Announces Publication of 10-Year Single-Center ...
PESTLE Analysis of Delcath Systems – businessmodelcanvastemplate.com
Delcath Systems' dramatic pivot to profitability explained (DCTH deep ...
Delcath Systems Projects 2026 Revenue of at Least $100 Million
Cancer: Delcath lands expanded CE Mark for organ-isolating chemo ...
Delcath Systems Q1 2026 earnings call set for May 7 | DCTH Stock News
Delcath bags orphan drug designation for drug/device combo to treat ...
Delcath Systems to Participate in Investor Conferences, Focus on Liver ...
Delcath Systems Secures $35M Following FDA Approval of HEPZATO KIT ...
Delcath Systems Fireside Chat @ Lytham Partners 2024 Investor Select ...
BTIG starts Delcath Systems at buy; PT $23 - BioTuesdays
Delcath - 2026 Company Profile, Funding, Competitors & Financials - Tracxn
Delcath Systems (DCTH) Investor Presentation - Slideshow (NASDAQ:DCTH ...
Delcath Systems Publishes Subgroup Analyses of The P-III Study on ...
Delcath Systems Q1 2026 revenue rises to $25M | DCTH Quarterly Report ...
Delcath Systems Highlights Two ASCO 2026
Delcath Systems, Inc (@DelcathSystems) / Posts / X
Delcath Systems Presentation @ Lytham Partners Fall 2023 Investor ...
Delcath Systems, Inc. (DCTH) Stock Price, Quote & News
Delcath Systems | FML CPAs
Delcath Systems IB 12-10-07 | PDF
Delcath officials appear before FDA panel today - Albany Business Review
DELCATH SYSTEMS, INC. - FORM 8-K - EX-99.1 - INVESTOR PRESENTATION ...
Delcath Data Reveals HEPZATO KIT Benefits Patients Across All Subgroups ...
Delcath Systems Careers | Levels.fyi
Delcath Systems Inc - Table of Contents Forward-Looking Statement 3 ...
Delcath systems Inc(NASDAQ: DCTH) : 네이버 블로그
Research & Educational Support - Delcath
Delcath Systems announces new drug application resubmission for Hepzato Kit
Delcath Systems, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Delcath Systems, Inc. - ROE
Delcath Systems | Grafa
What are the Porter's Five Forces of Delcath Systems ...
CIRSE 2017 Round-up: Delcath touts second-gen hemofiltration system in ...
Delcath Announces Poster Presentation at the 2022 ASCO Annual Meeting
Delcath Systems raises another $9.5m - Drug Delivery Business
Delcath raises $35m in private placement - MassDevice
Delcath Systems (DCTH) Stock Soared 62.5% on FDA Kit Approval
Delcath Systems Closes $6.2 Million Private Placement | citybiz
Delcath Systems Is Prepared For A U.S. Commercial Launch (NASDAQ:DCTH ...
Delcath Systems (DCTH) Strong Growth and Good Value in Q1 2025
Delcath Systems announces additional funding for Hepzato Kit FDA ...
Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit
Delcath Systems Q1 2026: -$0.03 EPS Tops Estimates — Deep Dive ...
Delcath Systems (NASDAQ: DCTH) stock up 66% premarket on FDA approval
Delcath Systems - Teams | The Org
Delcath launches Phase III trial for ocular melanoma treatment - Drug ...
Delcath inks European licensing deal for Chemosat - Drug Delivery Business
Delcath Systems tanks following reverse stock split - Drug Delivery ...
Delcath Systems ticks up despite missed Q1 projections - MassDevice
57th OOG Meeting in Berlin/Germany - Congress-Organisation Gerling GmbH
See 2024 CURE OM Patient & Caregiver Symposium
HEPZATO KIT™ Access
Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market ...
Treatment of Liver Metastases from Uveal Melanoma with Percutaneous ...
Form 8-K - Current report
Anesthesia-specific Protocol for Percutaneous Hepatic Perfusion ...
Diagram of the complete percutaneous hepatic perfusion circuit for ...
Use of Partial Venovenous Cardiopulmonary Bypass in Percutaneous ...
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver ...
7
Treatment of Intrahepatic Cholangiocarcinoma | Encyclopedia MDPI
secure
DCTH Q1 2025 Earnings Report on 5/8/2025
Slide 38
(PDF) Extrakorporale Perfusion mit dem Delcath-System: Methodik der ...
Slide 4
On-Demand Webinars
【即時新聞】Delcath Systems公佈FOCUS研究子群分析結果，揭示治療潛力 | CMoney投資網誌
FDA approval of Hepzato Kit for the treatment of adult patients with ...
Delcath's 2025 Growth Trajectory and HEPZATO Momentum: Strategic ...
【即時新聞】Delcath Systems 營收超預期，主力產品熱銷帶動全年營收突破 8500 萬美元 | CMoney投資網誌
DCTH Q4 2024 Earnings Report on 3/6/2025
100 Stock Ideas Heading Into 2026
Cartoon reproducing the CHEMOSAT ® percutaneous hepatic perfusion ...
HEPZATO KIT™
DCTH Q3 2025 Earnings Report on 11/4/2025
DCTH Q4 2025 Earnings Report on 2/26/2026
Slide 3
